Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting

Forster, Michael; Gehringer, Matthias; Laufer, Stefan A.

dc.contributor.author	Forster, Michael
dc.contributor.author	Gehringer, Matthias
dc.contributor.author	Laufer, Stefan
dc.date.accessioned	2019-05-07T09:22:04Z
dc.date.available	2019-05-07T09:22:04Z
dc.date.issued	2017
dc.identifier.issn	1464-3405
dc.identifier.uri	http://hdl.handle.net/10900/88403
dc.language.iso	en	de_DE
dc.publisher	Pergamon - Elsevier Science Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.bmcl.2017.07.079	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	540	de_DE
dc.title	Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_01140
utue.publikation.seiten	4229-4237	de_DE
utue.personen.roh	Forster, Michael
utue.personen.roh	Gehringer, Matthias
utue.personen.roh	Laufer, Stefan A.
dcterms.isPartOf.ZSTitelID	Bioorganic & Medicinal Chemistry Letters	de_DE
dcterms.isPartOf.ZS-Issue	18	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE